Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : SNY crawled date : 2021 - 03 - 12 save search
Global Pharma and Biotech Discovery Stage Partnering Terms and Agreements Directory 2014-2021
Published: 2021-03-12 (Crawled : 20:00) - prnewswire.com
SNY | News | $47.85 1.49% 920K
|
Health Technology
| Email alert
Add to watchlist
biotech iot pharma
Global Preclinical Stage Partnering Terms and Agreements in Pharma and Biotech 2021: Comprehensive Listing of 1,800+ Preclinical Stage Partnering Deals Announced Since 2014
Published: 2021-03-12 (Crawled : 20:00) - prnewswire.com
SNY | News | $47.85 1.49% 920K
|
Health Technology
| Email alert
Add to watchlist
biotech iot preclinical pre-clinical
COVID-19 Vaccine News: Novavax Effective Against Variants; Sanofi/Translate Begin Early Trials
Published: 2021-03-12 (Crawled : 16:00) - biospace.com/
SNY | News | $47.85 1.49% 920K
|
Health Technology
|
| O: -0.06%
H: 0.48%
C: 0.42%
covid vaccine trial covid-19
COVID-19 Vaccine News: Novavax Effective Against Variants; Sanofi/Translate B...
Published: 2021-03-12 (Crawled : 15:00) - biospace.com/
SNY | News | $47.85 1.49% 920K
|
Health Technology
|
| O: -0.06%
H: 0.48%
C: 0.42%
covid vaccine covid-19
San Francisco Behavioral Economics Lab appointed Hellen Lozano as CMO
Published: 2021-03-12 (Crawled : 14:21) - biospace.com/
SNY | News | $47.85 1.49% 920K
|
Health Technology
|
| O: -0.06%
H: 0.48%
C: 0.42%
World Epilepsy Drugs Market and Global Epilepsy Drugs Competitor Market Share Scenario 2020-2027
Published: 2021-03-12 (Crawled : 13:00) - prnewswire.com
PFE | News A | $26.24 -0.08% 11M
|
Health Technology
|
| O: -0.43%
H: 1.22%
C: 1.1%
NVS | News | $97.31 2.3% 2.3M
|
Health Technology
|
| O: -1.0%
H: 0.35%
C: 0.29%
JNJ | News | $150.09 0.65% 3.9M
|
Health Technology
|
| O: 0.09%
H: 0.65%
C: 0.2%
GSK | News | $41.13 1.33% 1.1M
|
Health Technology
|
| O: -0.31%
H: 0.31%
C: 0.28%
ABT | News | $108.01 0.88% 1.2M
|
Health Technology
|
| O: -0.37%
H: 0.15%
C: -0.32%
SNY | News | $47.85 1.49% 920K
|
Health Technology
|
| O: -0.06%
H: 0.48%
C: 0.42%
drug market
Sanofi and Translate Bio initiate Phase 1/2 clinical trial of mRNA COVID-19 vaccine candidate
Published: 2021-03-12 (Crawled : 07:00) - globenewswire.com
TBIO | $0.334 5.96% 130K
|
Health Technology
|
| O: 4.53%
H: 0.91%
C: -2.26%
SNY | News | $47.85 1.49% 920K
|
Health Technology
|
| O: -0.06%
H: 0.48%
C: 0.42%
covid phase 1 vaccine trial phase 3 phase 2 covid-19
Gainers vs Losers
| 87% | 13% |
Top 10 Gainers
MTTR | News M | $4.64 166.67% 18M
|
AGBA | $2.61 108.8% 41M
|
Finance
CZOO | $9.32 86.77% 18M
|
EDBL | News | $6.7 78.19% 1.7M
|
OPRT | News | $3.37 49.78% 8.9M
|
Finance
MTC | $2.14 37.18% 4.9M
|
Technology Services
VNRX | $0.8 33.33% 2.9M
|
Health Technology
MLEC | $1.79 27.86% 2.6M
|
n/a
PALI | $6.29 27.59% 22M
|
Manufacturing
MCRB | $0.7902 26.51% 6.9M
|
Health Technology
Your saved searches
Save your searches and get alerts when important news are released.